Back to Agenda
Conference Insights and Outcomes – Rapid Fire Session
Speaker(s)
Klaus Cichutek, PhD
Paul-Ehrlich-Institut, Germany
Director
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Isabelle de Zegher, DrMed, MD, MS, MSc
b!loba, Belgium
Founder
Danie Du Plessis, MD, MBA
The Next Version, United Kingdom
Managing Director and Owner
João Duarte, MPharm, MSc
Ipsen, France
Vice President, Head of Global Regulatory Affairs Excellence
Robert Hemmings, MSc
Critical Path Institute, Netherlands
Esteban Herrero-Martinez, PhD
Novartis Pharmaceuticals UK Limited, United Kingdom
Director Regulatory Policy and Intelligence
Camille Metais, MSc
Alexion Pharma GmbH, Switzerland
Senior Director Regulatory Affairs
Claudine Sapède, PharmD
NOVARTIS INTERNATIONAL, Switzerland
Director, Global HTA Policy
Peter Schueler, DrMed, MD
ICON plc (CRO), Germany
Senior Vice President, Drug Development Neurosciences
Sabine Straus, MD, PhD, MSc
Medicines Evaluation Board (MEB), Netherlands
Former PRAC Chair
Koen Torfs
Actelion, Switzerland
Head of Market Access & Pricing
Rebecca Vermeulen, RPh
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Chris Walker, MSc
Amgen, United Kingdom
VP, Head of Regulatory Affairs (EU,LATAM,MiddleEast,Africa,CAN)
Have an account?